Prostate Cancer
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review.
August 5, 2024
Apalutamide for High-Risk Localized Prostate Cancer Following Radical Prostatectomy (Apa-RP).
August 5, 2024
Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.
August 5, 2024
Incidence and Pitfalls of Adipose Tissue Encountered in Prostatic Transurethral Resections and Related Specimens.
August 5, 2024
LX1 Targets Androgen Receptor Variants and AKR1C3 to overcome Therapy Resistance in Advanced Prostate Cancer.
August 5, 2024
The Influence of Disparities on Prostate Cancer at Diagnosis in the Charlotte Metropolitan Area.
August 2, 2024
Treatment patterns for patients with BRCA1/2-positive metastatic castration-resistant prostate cancer.
August 2, 2024